Continuous presence of Th1 conditions is necessary for longer lasting tumor-specific CTL activity in stimulation cultures with PBL

Human Immunology

Volumn 66, Issue 8, 2005, Pages 884-891

  Chattopadhyay, Subhasis ^a   Chakraborty, Nitya G ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

CTL; Cytokine; Melanoma; PBL

Indexed keywords

GAMMA INTERFERON; HLA A2 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 4 ANTIBODY; MELAN A; TETRAMER;

ANTIGEN SPECIFICITY; ARTICLE; CELL ACTIVITY; CELL GROWTH; CELL POLARITY; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE COUNT; MELANOMA; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; STAINING; STATISTICAL SIGNIFICANCE; TH1 CELL; TUMOR CELL;

CANCER VACCINES; CYTOKINES; HLA-A2 ANTIGEN; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TUMOR CELLS, CULTURED;

EID: 26244464685     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2005.06.002     Document Type: Article

References (34)

1. G. Torre-Amione, R.D. Beauchamp, H. Koeppen, B.H. Park, H. Schreiber, H.L. Moses, D.A. Rowley A highly immunogenic tumor transfected with a murine transforming growth factor type 1 cDNA escapes immune surveillance Proc Natl Acad Sci U S A 87 1990 1486
2. G. Pawelec Tumour escape antitumour effectors too much of a good thing? Cancer Immunol Immunother 53 2004 262
3. L. Rivoltini, M. Carrabba, V. Huber, C. Castelli, L. Novellino, P. Dalerba, R. Mortarini, G. Arancia, A. Anichini, S. Fais, G. Parmiani Immunity to cancer attack and escape in T lymphocyte-tumor cell interaction Immunol Rev 188 2002 97
4. K. Staveley-O'Carroll, E. Sotomayor, J. Montgomery, I. Borrello, L. Hwang, S. Fein, D. Pardoll, H. Levitsky Induction of antigen-specific T cell anergy an early event in the course of tumor progression Proc Natl Acad. Sci U S A 95 1998 1178
5. P.P. Lee, C. Yee, P.A. Savage, L. Fong, D. Brockstedt, J.S. Weber, D. Johnson, S. Swetter, J. Thompson, P.D. Greenberg, M. Roederer, M.M. Davis Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients Nat Med 5 1999 677
6. D.M. Pardoll Cancer vaccines Nat Med 4 1998 525
7. S.J. Prasad, K.J. Farrand, S.A. Matthews, J.H. Chang, R.S. McHugh, F. Ronchese Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4+CD25+ regulatory T cells J Immunol 174 2005 90
8. F. Cottrez, H. Groux Specialization in tolerance innate CD(4+)CD(25+) versus acquired TR1 and TH3 regulatory T cells Transplantation 77 2004 S12
9. N.G. Chakraborty, L. Li, J.R. Sporn, S.H. Kurtzman, M.T. Ergin, B. Mukherji Emergence of regulatory CD4+ T cell response to repetitive stimulation with antigen-presenting cells in vitro implications in designing antigen-presenting cell-based tumor vaccines J Immunol 162 1999 5576
10. N.G. Chakraborty, S. Chattopadhyay, S. Mehrotra, A. Chhabra, B. Mukherji Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma Hum Immunol 65 2004 794
11. J.I. Mayordomo, T. Zorina, W.J. Storkus, L. Zitvogel, C. Celluzzi, L.D. Falo, C.J. Melief, S.T. Ildstad, W.M. Kast, A.B. Deleo Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity Nat Med 1 1995 1297
12. F.O. Nestle, S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, R. Dummer, G. Burg, D. Schadendorf Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells Nat Med 4 1998 328
13. J.M. Specht, G. Wang, M.T. Do, J.S. Lam, R.E. Royal, M.E. Reeves, S.A. Rosenberg, P. Hwu Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases J Exp Med 186 1997 1213
14. K. Dabbagh, D.B. Lewis Toll-like receptors and T-helper-1/T-helper-2 responses Curr Opin Infect Dis 16 2003 199
15. R. Waehler, H. Ittrich, L. Mueller, G. Krupski, D. Ameis, F. Schnieders Low-dose adenoviral immunotherapy of rat hepatocellular carcinoma using single-chain interleukin-12 Hum Gene Ther 16 2005 307
16. M. Croce, R. Meazza, A.M. Orengo, L. Radic, B. De Giovanni, C. Gambini, B. Carlini, V. Pistoia, L. Mortara, R.S. Accolla, M.V. Corrias, S. Ferrini Sequential immunogene therapy with interleukin-12- and interleukin-15-engineered neuroblastoma cells cures metastatic disease in syngeneic mice Clin Cancer Res 11 2005 735
17. K.L. Knutson, M.L. Disis Tumor antigen-specific T helper cells in cancer immunity and immunotherapy Cancer Immunol Immunother 2005 [Epub ahead of print].
18. Y. Yang, C.-T. Huang, X. Huang, D.M. Pardoll Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance Nature Immunol 5 2004 508
19. S. Mehrotra, A. Chhabra, S. Chattopadhyay, D.I. Dorsky, N.G. Chakraborty, B. Mukherji Rescuing melanoma epitope-specific cytolytic T lymphocytes from activation-induced cell death, by SP600125, an inhibitor of JNK implications in cancer immunotherapy J Immunol 173 2004 6017
20. S. Mehrotra, R. Stevens, R. Zengou, N.G. Chakraborty, L.H. Butterfield, J.S. Economou, D.I. Dorsky, B. Mukherji Regulation of melanoma epitope-specific cytolytic T lymphocyte response by immature and activated dendritic cells, in vitro Cancer Res 63 2003 5607
21. F. Sallusto, C.R. Mackay, A. Lanzavecchia Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells Science 277 1997 2005
22. N.P. Restifo, F. Esquivel, Y. Kawakami, J.W. Yewdell, J.J. Mule, S.A. Rosenberg, J.R. Bennink Identification of human cancers deficient in antigen processing J Exp Med 177 1993 265
23. C. Beck, H. Schreiber, D. Rowley Role of TGF-beta in immune-evasion of cancer Microsc Res Tech 52 2001 387
24. F. Salazar-Onfray Interleukin-10 a cytokine used by tumors to escape immunosurveillance Med Oncol 16 1999 86
25. T. Takahashi, S. Sakaguchi Naturally arising CD25+CD4+ regulatory T cells in maintaining immunologic self-tolerance and preventing autoimmune disease Curr Mol Med 3 2003 693
26. M. Kuwana Induction of anergic and regulatory T cells by plasmacytoid dendritic cells and other dendritic cell subsets Hum Immunol 63 2002 1156
27. G. Vlad, R. Cortesini, N. Suciu-Foca License to heal bidirectional interaction of antigen-specific regulatory t cells and tolerogenic APC J Immunol 174 2005 5907
28. J. Galea-Lauri, J.W. Wells, D. Darling, P. Harrison, F. Farzaneh Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination Cancer Immunol Immunother 53 2004 963
29. R.F. Wang Enhancing antitumor immune responses intracellular peptide delivery and identification of MHC class II-restricted tumor antigens Immunol Rev 188 2002 65
30. B. Pulendran Modulating TH1/TH2 responses with microbes, dendritic cells, and pathogen recognition receptors Immunol Res 29 2004 187
31. H.Y. Wang, D.A. Lee, G. Peng, Z. Guo, Y. Li, Y. Kiniwa, E.M. Shevach, R.F. Wang Tumor specific human CD4+ regulatory T cells and their ligands implications for immunotherapy Immunity 20 2004 107
32. J. Shimizu, S. Yamazaki, S. Sakaguchi Induction of tumor immunity by removing CD25+CD4+ T cells acommon basis between tumor immunity and autoimmunity J Immunol 163 1999 5211
33. T.J. Curiel, G. Coukos, L. Zou, X. Alvarez, P. Cheng, P. Mottram, M. Evdemon-Hogan, J.R. Conejo-Garcia, L. Zhang, M. Burow, Y. Zhu, S. Wei, I. Kryczek, B. Daniel, A. Gordon, L. Myers, A. Lackner, M.L. Disis, K.L. Knutson, L. Chen, W. Zou Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat Med 10 2004 942
34. S. Chattopadhyay, N.G. Chakraborty, B. Mukherji Regulatory T cell and tumor immunity Cancer Immunol Immunother 2005 [Epub ahead of print].